FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Irwin & Joan Jacobs Trust Dated 6-2-80		 2. Issuer Name and Ticker or Trading Symbol

DermTech, Inc. [ DMTK ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    __X__ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

2710 IVERNESS COURT		 3. Date of Earliest Transaction (MM/DD/YYYY)

5/11/2020
(Street)

LA JOLLA, CA 92037
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
 6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 5/11/2020  X  41932 A$9.54 1808434 D (1) 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)		2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)		8. Price of Derivative Security
(Instr. 5)		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Warrant (right to buy) $9.54 5/11/2020  X     41932  5/11/2017 5/11/2020 Common Stock 41932 $0.00 0 D (1) 
Explanation of Responses:
(1) These securities are directly owned by the Irwin & Joan Jacobs Trust Dated 6-2-80. Irwin Jacobs and Joan Jacobs are the trustees of the Irwin & Joan Jacobs Trust Dated 6-2-80 and, in such capacity, may each be deemed to indirectly beneficially own the securities owned by the Irwin & Joan Jacobs Trust Dated 6-2-80.
Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Irwin & Joan Jacobs Trust Dated 6-2-80
2710 IVERNESS COURT
LA JOLLA, CA 92037
X

JACOBS IRWIN M
2710 IVERNESS COURT
LA JOLLA, CA 92037
X

Jacobs Joan
2710 IVERNESS COURT
LA JOLLA, CA 92037
X
Signatures
Jason S. Miller, as attorney-in-fact to the Irwin & Joan Jacobs Trust Dated 6-2-805/13/2020
**Signature of Reporting PersonDate

Jason S. Miller, as attorney-in-fact to Irwin Jacobs5/13/2020
**Signature of Reporting PersonDate

Jason S. Miller, as attorney-in-fact to Joan Jacobs5/13/2020
**Signature of Reporting PersonDate
DermTech (PK) (USOTC:DMTKW)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more DermTech (PK) Charts.
DermTech (PK) (USOTC:DMTKW)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more DermTech (PK) Charts.